Fri. Nov 8th, 2024

Eli Lilly’s ‘game-changing’ diabetes drug could boost the stock, SVB Securities says

May 23, 2022

Eli Lilly’s new diabetes drug, which may also address obesity in patients, could lead to even more gains for the company’s stock, according to SVB Securities.

Related Post

Here’s how the Supreme Court’s Roe v. Wade decision could affect health insurance coverage

Jun 27, 2022

Women in states that ban abortion will still be able to get abortion pills online from overseas

Jun 27, 2022

Here’s how the Supreme Court’s Roe v. Wade decision could affect health insurance coverage

Jun 27, 2022

News You May Have Missed

How the Trump Presidency Might Change the Global Economy | naked capitalism

Nov 7, 2024

Israeli Strikes Killed at Least 40 in Eastern Lebanon, Health Ministry Says

Nov 7, 2024

Bank of England Cuts Interest Rates, but Warns Inflation Will Fall Slowly

Nov 7, 2024

Kamala Harris Was the Establishment in an Anti-Establishment Election

Nov 7, 2024